Blueprint Medicines
BPMC
#2500
Rank
A$8.63 B
Marketcap
$135.10
Share price
-6.23%
Change (1 day)
-1.85%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -$13.83

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -$15.20. In 2022 the company made an earnings per share (EPS) of -$15.46 an increase over its 2021 EPS that were of -$18.16.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$13.83-10.6%
2022-$15.46-14.85%
2021-$18.16-297.13%
2020$9.21-176.3%
2019-$12.0735.19%
2018-$8.9338.82%
2017-$6.4347.35%
2016-$4.379.25%
2015-$4.00-31.35%
2014-$5.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.12-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.45-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.10-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA